A methodology to extract outcomes from routine healthcare data for patients with locally advanced non-small cell lung cancer
Abstract Background Outcomes for patients in UK with locally advanced non-small cell lung cancer (LA NSCLC) are amongst the worst in Europe. Assessing outcomes is important for analysing the effectiveness of current practice. However, data quality is inconsistent and regular large scale analysis is...
Saved in:
Main Authors: | Swee-Ling Wong (Author), Kate Ricketts (Author), Gary Royle (Author), Matt Williams (Author), Ruheena Mendes (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2018-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Cost-Effectiveness of Tislelizumab Plus Chemotherapy for Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer
by: Xia Luo, et al.
Published: (2022) -
Achievement of long-term local control after radiation and anti-PD-1 immunotherapy in locally advanced non-small cell lung cancer
by: Zhao Jing, et al.
Published: (2021) -
Evaluation of changes in tumor volume following upfront chemotherapy for locally advanced Non Small Cell Lung Cancer (NSCLC)
by: Omer Sager, et al.
Published: (2021) -
Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year results
by: Candelaria Myrna, et al.
Published: (2006) -
Exploring the implications of modified advanced lung cancer inflammation index on outcomes in patients with advanced non-small cell lung cancer
by: Abhishek Mahajan, et al.
Published: (2023)